StarTribune
Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers will not pursue accelerated approval

By: MarketMinute.com Stock News

Bristol-Myers Squibb Co. (NYSE: BMY) will not pursue accelerated approval for its lung cancer treatment Opdivo sending the stock price plummeting $6.26 to close at $49.23.



Related Stocks:
Bristol-Myers Squibb
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
Browse Business Sections
Latest Columns
Elsewhere in Business
  1. 9m
    How major US stock indexes fared Thursday, 4/18/2024
  2. 15m
    Ally Financial, CSX rise; Equifax, Synovus Financial fall, Thursday, 4/18/2024
  3. 24m
    Stock market today: Wall Street drifts to a mixed finish as yields tick higher
  4. 31m
    World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
  5. 38m
    Closing prices for crude oil, gold and other commodities
  6. 41m
    Liquor sales in movie theaters, to-go sales of cocktails included in New York budget agreement
  7. 52m
    Sluggish start for spring homebuying season as home sales fall in March with mortgage rates rising
  8. 53m
    Missouri lawmakers back big expansion of low-interest loans amid growing demand for state aid
  9. 54m
    Average long-term US mortgage rate climbs above 7% to highest level since late November
  10. 58m
    Shares of Walmart-backed Ibotta soar on public debut
Most Read
  1. Burnsville woman's sinus surgery went great — until she got the $32,449 medical bill • Business
  2. Ramstad: Misinterpreting data led me to the wrong conclusion about Minnesota retirees • Business
  3. Right-wing conservatives object to Vista's deal to sell Federal ammunition to Czech firm • Business
  4. Why you should donate clothing: It (probably) won't end up at the dump • Business
  5. Minnesota added thousands of jobs in March but worker shortage still an issue • Business

Business

Complete coverage of business news in the Twin Cities, Minnesota and elsewhere, including Fortune 500 Minnesota companies: UnitedHealth Group, Target, Best Buy, 3M, CHS, U.S. Bancorp, General Mills, C.H. Robinson, Land O’Lakes, Ecolab, Ameriprise Financial, Xcel Energy, Hormel Foods, Thrivent Financial, Polaris, Securian Financial Group, Fastenal and Patterson Cos.

© 2024 StarTribune. All rights reserved.